Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,178 | 2,045 | 2,387 | 1,735 | 1,797 |
| Receivables | 0 | 8 | 1 | N/A | N/A |
| Inventories | 182 | 106 | 71 | 45 | 27 |
| Other current assets | 8 | 8 | 8 | 8 | 8 |
| TOTAL | $13,405 | $2,196 | $2,492 | $1,804 | $1,842 |
| Non-Current Assets | |||||
| PPE Net | 4 | 7 | 10 | 14 | 17 |
| TOTAL | $4 | $7 | $10 | $14 | $17 |
| Total Assets | $13,409 | $2,203 | $2,502 | $1,817 | $1,859 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 95 | 43 | 57 | 103 | 149 |
| Accrued Expenses | N/A | 48 | 85 | 59 | 52 |
| TOTAL | $95 | $91 | $472 | $636 | $865 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,900 | 3,204 | 2,054 | 2,078 |
| TOTAL | $N/A | $1,900 | $3,204 | $2,054 | $2,078 |
| Total Liabilities | $95 | $1,991 | $3,676 | $2,690 | $2,943 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8 | 4 | 258 | 255 | 240 |
| Common Shares | 7 | 3 | 510 | 486 | 465 |
| Retained earnings | -33,891 | -32,655 | -33,322 | -29,283 | -26,404 |
| Other shareholders' equity | -22 | -23 | -17 | -12 | -5 |
| TOTAL | $13,314 | $212 | $-1,174 | $-873 | $-1,084 |
| Total Liabilities And Equity | $13,409 | $2,203 | $2,502 | $1,817 | $1,859 |